Differential Prevalences of Pfmdr1 Polymorphisms in Symptomatic and Asymptomatic Plasmodium falciparum Infections in Lastoursville: A Rural Area in East-Central Gabon

References

• World Health Organization. World Malaria Report 2020. Vol. 299. World Health Organization; 2020.
   Google Scholar
• World Health Organization. Guidelines for the Treatment of Malaria. World Health Organization; 2006.
   Google Scholar
• Le Bras J. Chimiorésistance de Plasmodium falciparum. Médecine Mal Infect. 1999;29:S274–S281. doi:10.1016/S0399-077X(00)88264-5
   Web of Science ®Google Scholar
• Jelinek T, Schelbert P, Löscher T, Eichenlaub D. Quinine resistant falciparum malaria acquired in east Africa. Trop Med Parasitol Off Organ Dtsch Tropenmedizinische Ges Dtsch Ges Tech Zusammenarbeit GTZ. 1995;46:38–40.
   Google Scholar
• Ashley EA, Dhorda M, Fairhurst RM, et al. Spread of artemisinin resistance in Plasmodium falciparum Malaria. N Engl J Med. 2014;371:411–423. doi:10.1056/NEJMoa131498125075834
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in plasmodium falciparum malaria. N Engl J Med. 2009;361(5):455–467. doi:10.1056/NEJMoa080885919641202
   PubMed Web of Science ®Google Scholar
• Duraisingh MT, Cowman AF. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005;94:181–190. doi:10.1016/j.actatropica.2005.04.00815876420
   PubMed Web of Science ®Google Scholar
• Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 2000;403(6772):906–909. doi:10.1038/3500261510706290
   PubMed Web of Science ®Google Scholar
• Venkatesan M, Gadalla NB, Stepniewska K, et al. Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine. Am J Trop Med Hyg. 2014;91:833–843. doi:10.4269/ajtmh.14-003125048375
   PubMed Web of Science ®Google Scholar
• Henriques G, Hallett RL, Beshir KB, et al. Directional Selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu Loci of Plasmodium falciparum in Kenyan Children Treated With ACT. J Infect Dis. 2014;210:2001–2008. doi:10.1093/infdis/jiu35824994911
   PubMed Web of Science ®Google Scholar
• Ochong E, Tumwebaze P, Byaruhanga O, Greenhouse B, Rosenthal P. Fitness Consequences of Plasmodium falciparum pfmdr1 Polymorphisms Inferred from Ex Vivo Culture of Ugandan Parasites. Antimicrob Agents Chemother. 2013;57:4245–4251. doi:10.1128/AAC.00161-1323796921
   PubMed Web of Science ®Google Scholar
• Hayward R, Saliba KJ, Kirk K. pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol Microbiol. 2005;55:1285–1295. doi:10.1111/j.1365-2958.2004.04470.x15686571
   PubMed Web of Science ®Google Scholar
• Tukwasibwe S, Tumwebaze P, Conrad M, et al. Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda. Malar J. 2017;16:125. doi:10.1186/s12936-017-1777-028327148
   PubMed Web of Science ®Google Scholar
• Ndong JMM, Atteke C, Aubouy A, et al. In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum. Trop Med Int Health. 2003;8:25–29. doi:10.1046/j.1365-3156.2003.00967.x12535246
   PubMed Web of Science ®Google Scholar
• Pradines B, Mamfoumbi MM, Parzy D, et al. In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine. Parasitology. 1998;117:541–545. doi:10.1017/S00311820980034009881378
   PubMed Web of Science ®Google Scholar
• Bouyou-Akotet MK, Mawili-Mboumba DP, Kendjo E, et al. Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008. Malar J. 2009;8:300. doi:10.1186/1475-2875-8-30020017905
   PubMed Web of Science ®Google Scholar
• Lekana-Douki JB, Boutamba SDD, Zatra R, et al. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether–lumefantrine and artesunate–mefloquine. Infect Genet Evol. 2011;11:512–517. doi:10.1016/j.meegid.2011.01.00321251998
   PubMed Web of Science ®Google Scholar
• Assele V, Ndoh GE, Nkoghe D, Fandeur T. No evidence of decline in malaria burden from 2006 to 2013 in a rural Province of Gabon: implications for public health policy. BMC Public Health. 2015;15(1):81. doi:10.1186/s12889-015-1456-425649228
   PubMed Web of Science ®Google Scholar
• Mawili-Mboumba DP, Akotet MKB, Kendjo E, et al. Increase in malaria prevalence and age of at risk population in different areas of Gabon. Malar J. 2013;12:3. doi:10.1186/1475-2875-12-323282198
   PubMed Web of Science ®Google Scholar
• Maghendji-Nzondo S, Kouna L-C, Mourembou G, et al. Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children. Malar J. 2016;15:420. doi:10.1186/s12936-016-1469-127538948
   PubMed Web of Science ®Google Scholar
• Pegha Moukandja I, Biteghe Bi Essone JC, Sagara I, et al. Marked rise in the prevalence of asymptomatic plasmodium falciparum infection in rural gabon. PLoS One. 2016;11(5):e0153899. doi:10.1371/journal.pone.015389927228058
   PubMed Web of Science ®Google Scholar
• Zatra R, Lekana-douki JB, Lekoulou F, et al. In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon. BMC Infect Dis. 2012;12:307. doi:10.1186/1471-2334-12-30723153201
   PubMed Web of Science ®Google Scholar
• Pegha-Moukandja I, Charlene Kouna L, Maghendji-Nzdondo S, et al. Pfmdr1 gene polymorphism of Plasmodium falciparum isolates from asymptomatic individuals of Dienga, southeastern Gabon. J Parasit Dis Diagn Ther. 2018;3:18–25. doi:10.4066/2591-7846.1000024
   Google Scholar
• Tukwasibwe S, Mugenyi L, Mbogo GW, et al. Differential Prevalence of Transporter Polymorphisms in Symptomatic and Asymptomatic Falciparum Malaria Infections in Uganda. J Infect Dis. 2014;210:154–157. doi:10.1093/infdis/jiu04424446524
   PubMed Web of Science ®Google Scholar
• Ogouyèmi-Hounto A, Ndam NT, Kinde Gazard D, et al. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy. Malar J. 2013;12:147. doi:10.1186/1475-2875-12-14723634705
   PubMed Web of Science ®Google Scholar
• Wélé M, Djimdé AA, Guindo A, et al. High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria. Acta Trop. 2011;119(1):11–13. doi:10.1016/j.actatropica.2011.01.00221300016
   PubMed Web of Science ®Google Scholar
• Planche T, Ngou-Milama E, Kremsner PG, et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg. 2001;65:599–602. doi:10.4269/ajtmh.2001.65.59911716121
   PubMed Web of Science ®Google Scholar
• Snounou G, Viriyakosol S, Ping Zhu X, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315–320. doi:10.1016/0166-6851(93)90077-B8264734
   PubMed Web of Science ®Google Scholar
• Cox-Singh J, Singh B, Alias A, Abdullah MS. Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg. 1995;89:436–437. doi:10.1016/0035-9203(95)90045-47570891
   PubMed Web of Science ®Google Scholar
• Price RN, Cassar C, Brockman A, et al. The pfmdr1 Gene Is Associated with a Multidrug-Resistant Phenotype in Plasmodium falciparum from the Western Border of Thailand Antimicrob. Agents Chemother. 1999;43:2943–2949. doi:10.1128/AAC.43.12.2943
   PubMed Web of Science ®Google Scholar
• Woldearegai TG, Lalremruata A, Nguyen TT, et al. Characterization of Plasmodium infections among inhabitants of rural areas in Gabon. Sci Rep. 2019;9:1–10. doi:10.1038/s41598-019-46194-930626917
   PubMed Web of Science ®Google Scholar
• Eke RA, Chigbu LN. High Prevalence of Asymptomatic Plasmodium Infection in a Suburb of Aba Town, Nigeria. Ann Afr Med. 2006;5:42–45.
   Google Scholar
• Mabunda S, Casimiro S, Quinto L, Alonso P. A country-wide malaria survey in Mozambique. I. Plasmodium falciparum infection in children in different epidemiological settings. Malar J. 2008;7:216. doi:10.1186/1475-2875-7-21618950486
   PubMed Web of Science ®Google Scholar
• Maghendji-Nzondo S, Nzoughe H, Lemamy GJ, et al. Prevalence of malaria, prevention measures, and main clinical features in febrile children admitted to the Franceville Regional Hospital, Gabon. Parasite. 2016;23:32. doi:10.1051/parasite/201603227492564
   PubMed Web of Science ®Google Scholar
• Lekana-Douki J-B, Pontarollo J, Zatra R, Toure-Ndouo FS. Paludisme au Gabon: résultats d’une étude bioclinique à l’hôpital de l’amitié sino-gabonaise de Franceville. Cah Détudes Rech Francoph Santé. 2011;21:193–198.
   Google Scholar
• Maina RN, Walsh D, Gaddy C, et al. Impact of Plasmodium falciparum infection on haematological parameters in children living in Western Kenya. Malar J. 2010;9:S4. doi:10.1186/1475-2875-9-S3-S421144084
   PubMed Web of Science ®Google Scholar
• Dokunmu TM, Adjekukor CU, Yakubu OF, et al. Asymptomatic malaria infections and Pfmdr1 mutations in an endemic area of Nigeria. Malar J. 2019;18:218. doi:10.1186/s12936-019-2833-831248414
   PubMed Web of Science ®Google Scholar
• Nkoghe D, Akue J-P, Gonzalez J-P, Leroy EM. Prevalence of Plasmodium falciparum infection in asymptomatic rural Gabonese populations. Malar J. 2011;10:33. doi:10.1186/1475-2875-10-3321306636
   PubMed Web of Science ®Google Scholar
• Mukomena SE, Philipe CM, Désiré MK, et al. Parasitémie asymptomatique chez les enfants de moins de 5 ans, enfants en âge scolaire et prise en charge des épisodes fébriles dans les ménages de Lubumbashi, République Démocratique du Congo. Pan Afr Med J. 2016;24:94. doi:10.11604/pamj.2016.24.94.935027642433
   PubMedGoogle Scholar
• Rodriguez-Barraquer I, Arinaitwe E, Jagannathan P, et al. Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure. eLife. 2018;7:e35832. doi:10.7554/eLife.3583230044224
   PubMed Web of Science ®Google Scholar
• Strøm GE, Tellevik MG, Fataki M, Langeland N, Blomberg B. No asymptomatic malaria parasitaemia found among 108 young children at one health facility in Dar es Salaam, Tanzania. Malar J. 2013;12:417. doi:10.1186/1475-2875-12-41724228811
   PubMed Web of Science ®Google Scholar
• Somé AF, Sorgho H, Zongo I, et al. Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso. Parasite. 2016;23:60. doi:10.1051/parasite/201606928004634
   PubMed Web of Science ®Google Scholar
• Okombo J, Kamau AW, Marsh K, Sutherland CJ, Ochola-Oyier LI. Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya. Int J Parasitol Drugs Drug Resist. 2014;4:152–163. doi:10.1016/j.ijpddr.2014.07.00325516825
   PubMed Web of Science ®Google Scholar
• Laufer M, Takala‐Harrison S, Dzinjalamala F, et al. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. J Infect Dis. 2010;202:801–808. doi:10.1086/65565920662717
   PubMed Web of Science ®Google Scholar
• Malmberg M, Ngasala B, Ferreira PE, et al. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania. Malar J. 2013;12:103. doi:10.1186/1475-2875-12-10323506218
   PubMed Web of Science ®Google Scholar
• Sisowath C, Ferreira PE, Bustamante LY, et al. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med Int Health. 2007;12:736–742. doi:10.1111/j.1365-3156.2007.01843.x17550470
   PubMed Web of Science ®Google Scholar
• Baliraine FN, Rosenthal PJ. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. J Infect Dis. 2011;204:1120–1124. doi:10.1093/infdis/jir48621881128
   PubMed Web of Science ®Google Scholar
• Humphreys GS, Merinopoulos I, Ahmed J, et al. Amodiaquine and Artemether-Lumefantrine Select Distinct Alleles of the Plasmodium falciparum mdr1 Gene in Tanzanian Children Treated for Uncomplicated Malaria. Antimicrob Agents Chemother. 2007;51:991–997. doi:10.1128/AAC.00875-0617194834
   PubMed Web of Science ®Google Scholar
• Malmberg M, Ferreira PE, Tarning J, et al. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J Infect Dis. 2013;207:842–847. doi:10.1093/infdis/jis74723225895
   PubMed Web of Science ®Google Scholar
• Okell LC, Reiter LM, Ebbe LS, et al. Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether–lumefantrine and artesunate–amodiaquine in Africa. BMJ Glob Health. 2018;3(5):e000999. doi:10.1136/bmjgh-2018-000999
   PubMed Web of Science ®Google Scholar
• Oyakhirome S, Pötschke M, Schwarz NG, et al. Artesunate – amodiaquine combination therapy for falciparum malaria in young Gabonese children. Malar J. 2007;6:29. doi:10.1186/1475-2875-6-2917352806
   PubMed Web of Science ®Google Scholar